Skip to main content
. 2017 Jan 23;8:14209. doi: 10.1038/ncomms14209

Figure 1. Disseminated EBV+ SMT in CARMIL2-deficient patients.

Figure 1

(a) Abdominal magnetic resonance (MRI; T1 fat-sat post contrast medium) image of P1.2 with a tumour of ∼6 cm diameter in liver segments I and V–VIII (white arrows). (b) Cranial MRI (T2-WI) of P1.2 with a tumour of ∼1.7 cm diameter in the dorsal medulla oblongata (white arrow). (c) Colonoscopy image of P1.2 with multiple protruding tumors in the colon. (d,e) P2.1 hematoxylin and eosin (H&E) stains with leiomyogenic tumour cells and (f) EBER in situ hybridization. Scale bars, 50 μm. MRI, colonoscopy, tumour histopathology and EBER stains have been performed for four patients (P1.1, P1.2, P2.1 and P2.2).